In the context of verifying medication orders, what best describes concurrent surveillance of an adverse drug event?

In the context of verifying medication orders, what best describes concurrent surveillance of an adverse drug event?

• A. Daily rounds to monitor patients on anticoagulants
• B. Recognizing the need for an anticoagulation reversal agent
• C. Using clinical decision support for renal function alerts
• D. Reviewing medical records post-adverse event

Answer: (B)

Concurrent surveillance of an adverse drug event involves actively monitoring patients in real-time to identify and respond to potential issues as they occur. In this context, recognizing the need for an anticoagulation reversal agent is a prime example of concurrent surveillance. When a patient is on anticoagulation therapy, there is a risk of bleeding or other adverse effects. By monitoring patients closely, healthcare professionals can quickly identify signs that may warrant the use of a reversal agent. This immediate recognition allows for timely intervention, potentially preventing serious complications from occurring. In contrast, activities like daily rounds to monitor patients on anticoagulants are certainly important but do not specifically focus on the recognition and response to an adverse event as it happens. Similarly, using clinical decision support for renal function alerts pertains to proactive assessment rather than real-time surveillance of adverse events. Reviewing medical records post-adverse event deals with analysis in hindsight rather than concurrent, real-time monitoring. Thus, recognizing the need for an anticoagulation reversal agent encapsulates the essence of concurrent surveillance in managing adverse drug events.

Concurrent surveillance of an adverse drug event involves actively monitoring patients in real-time to identify and respond to potential issues as they occur. In this context, recognizing the need for an anticoagulation reversal agent is a prime example of concurrent surveillance.

When a patient is on anticoagulation therapy, there is a risk of bleeding or other adverse effects. By monitoring patients closely, healthcare professionals can quickly identify signs that may warrant the use of a reversal agent. This immediate recognition allows for timely intervention, potentially preventing serious complications from occurring.

In contrast, activities like daily rounds to monitor patients on anticoagulants are certainly important but do not specifically focus on the recognition and response to an adverse event as it happens. Similarly, using clinical decision support for renal function alerts pertains to proactive assessment rather than real-time surveillance of adverse events. Reviewing medical records post-adverse event deals with analysis in hindsight rather than concurrent, real-time monitoring. Thus, recognizing the need for an anticoagulation reversal agent encapsulates the essence of concurrent surveillance in managing adverse drug events.